SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
52 hedge funds and large institutions have $104M invested in Sinovac Biotech, Ltd in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
39% less call options, than puts
Call options by funds: $268K | Put options by funds: $438K
Holders
52
Holding in Top 10
–
Calls
$268K
Puts
$438K
Top Buyers
| 1 | +$8.87M | |
| 2 | +$1.48M | |
| 3 | +$1.42M | |
| 4 |
Two Sigma Investments
New York
|
+$1.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$847K |
Top Sellers
| 1 | -$3.09M | |
| 2 | -$355K | |
| 3 | -$353K | |
| 4 |
Morgan Stanley
New York
|
-$253K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$231K |